Published in
Elsevier, The Lancet HIV, 4(10), p. e230-e243, 2023
DOI: 10.1016/s2352-3018(23)00003-6
Links
Tools
Safety and pharmacokinetics of escalating doses of neutralising monoclonal antibody CAP256V2LS administered with and without VRC07-523LS in HIV-negative women in South Africa (CAPRISA 012B): a phase 1, dose-escalation, randomised controlled trial
Journal article published in 2023 by
Sharana Mahomed,
Nigel Garrett,
Edmund V. Capparelli,
Farzana Osman,
Nonhlanhla N. Mkhize,
Ishana Harkoo,
Tanuja N. Gengiah,
Leila E. Mansoor,
Cheryl Baxter 
,
Derseree Archary,
Nonhlanhla Yende-Zuma,
Natasha Samsunder,
Kevin Carlton,
Sandeep Narpala,
Adrian B. McDermott
and other authors.
,
Derseree Archary,
Nonhlanhla Yende-Zuma,
Natasha Samsunder,
Kevin Carlton,
Sandeep Narpala,
Adrian B. McDermott
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 